USFDA approval for Alembic Pharma

April 10, 2017 | Monday | News | By BioSpectrum Bureau

USFDA approval for Alembic Pharma

The US Food and Drug Administration has given approval to Alembic Pharmaceuticals for generic Fluoxetine Hydrochloride tablets used for the treatment of depression and panic disorder.
This drug is a generic version of Prozac tablets manufactured by Eli Lilly and Company.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company based in Gujarat. The company has a total of 53 abbreviated new drug application (ANDA) approval from the US health regulator.

Fluoxetine Hydrochloride tablets are prescribed for treating major depressive disorders and obsessive compulsive disorder in adult and paediatric patients. Fluoxetine is a selective serotonin reuptake inhibitors (SSRI) antidepressant. It affects chemicals in the brain that may be unbalanced in people suffering from depression, panic, anxiety, or obsessive-compulsive symptoms.

The drug is available in the strengths of 10 and 20 mg. Common side effects associated with this drug include headache, dizziness, diarrhea, and weakness.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy